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A B S T R A C T
Background: For a better understanding of the current situation of drug use in Iran, we utilized the
network scale-up approach to estimate the prevalence of illicit drug use in the entire country.
Methods: We implemented a self-administered, street-based questionnaire to 7535 passersby from the
general public over 18 years of age by street based random walk quota sampling (based on gender, age
and socio-economic status) from 31 provinces in Iran. The sample size in each province was
approximately 400, ranging from 200 to 1000. In each province 75% of sample was recruited from the
capital and the remaining 25% was recruited from one of the large cities of that province through
stratiﬁed sampling. The questionnaire comprised questions on demographic information as well as
questions to measure the total network size of participants as well as the network size in each of seven
drug use groups including Opium, Shire (combination of Opium residue and pure opium), Crystal
Methamphetamine, heroin/crack (which in Iranian context is a cocaine-free drug that mostly contains
heroin, codeine, morphine and caffeine with or without other drugs), Hashish, Methamphetamine/LSD/
ecstasy, and injecting drugs. The estimated size for each group was adjusted for transmission and barrier
ratios.
Results: The most common type of illicit drug used was opium with the prevalence of 1500 per 100,000
population followed by shire (660), crystal methamphetamine (590), hashish (470), heroin/crack (350),
methamphetamine, LSD and ecstasy (300) and injecting drugs (280). All types of substances were more
common among men than women. The use of opium, shire and injecting drugs was more common in
individuals over 30 whereas the use of stimulants and hashish was largest among individuals between
18 and 30 years of age.
Conclusion: It seems that younger individuals and women are more desired to use new synthetic drugs
such as crystal methamphetamine. Extending the preventive programs especially in youth as like as
scaling up harm reduction services would be the main priorities in prevention and control of substance
use in Iran. Because of poor service coverage and high stigma in women, more targeted programs in this
affected population are needed.
 2016 Elsevier B.V. All rights reserved.
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Iran’s geographical location, especially its long border with
Afghanistan (which is the main grower of opium in the world) and
its proximity with Pakistan, has turned it into a major transit
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unemployment, substance smuggling and substance use is the
third major dilemma in Iranian society resulting in serious social,
economical and public health consequences (Moghanibashi-
Mansourieh & Deilamizade, 2014).
Most of our knowledge regarding the epidemiology and extent
of substance use in Iran is based on ofﬁcial reports of the Ministry
of Health (MOH) and Iranian Drug Control (DCHQ). Discrepancies
between these reports, though, make the picture of substance use
more ambiguous. In 2002, MOH and DCHQ estimated the number
of substance users in the population above 15 years Because of
some biases and methodological errors (e.g. sampling from
emergency clinics) the results were never announced or
distributed (Tafreshi, 2012). A rapid situation assessment and
analysis in 2007 estimated the number of substance users to be
1.2 million (corresponding to an adult prevalence of 2.4%). The
most common type of drug used was opium (34%) followed by
crack (which in Iran is a cocaine-free drug that mostly contains
heroin, codeine, morphine and caffeine with or without other
drugs) (26.6%), heroin (19.9%), shire (a combination of Opium
residue and pure opium) (4.4%), neurjezik (4.1%), crystal
methamphetamine (3.6%) and hashish (2%) (Narenjiha et al.,
2007). In this survey the opiate users were recruited from the
street, prisons and treatment clinics in 27 cities in Iran, which may
limit the generalizability of the results. The results of the latest
national household survey in 2011, conducted by DCHQ on 15,000
households, suggest that there are 1.325 million substance users
(corresponding to a prevalence of 2.65%) among people between
15 and 65 years old. Based on their report, the most prevalent
substances were opium (52.02%), crystal methamphetamine
(26.22%), crack (15.95%), heroin (9.77%), hashish (6.43%), ecstasy
(3.08%) and shire (2.83%) (Sarrami et al., 2013; Tafreshi, 2012).
Although these ofﬁcial reports provide policy makers somewhat
of a snapshot regarding the situation of substance use in Iran,
some practical and methodological problems (such as obtaining
data from prisoners, treatment seekers and street drug users,
stigma toward substance use in household surveys, and extraction
of information directly from the study population) lead to certain
challenges and debates regarding the pragmatic extent of
substance use in Iran. Furthermore, the diversity of the study
population and the methodology that was used in these surveys
may limit the monitoring of trends over time. The lack of valid and
generalizable information on substance use, therefore, is the main
challenge of drug use surveillance in Iran.
Network scale-up (NSU) is an indirect method of size
estimation in hidden populations that has been used to estimate
the size of hidden populations such as HIV-positive persons
(Killworth et al., 1998) substance users (Kadushin et al., 2006;
Salganik et al., 2011a), men who have sex with men (MSM) (Ezoe
et al., 2012) and (other) groups at higher risk of HIV (Moldova
UNAIDS Country Ofﬁce, 2010; Paniotto et al., 2009; Shokoohi
et al., 2012) around the world. Generally, every person knows
how many people he/she identiﬁes as his/her active social
network. The average number of hidden subgroups reported by
every respondent constitutes a fraction of their network. We are
therefore able to scale up this fraction to a fraction of the total
population and thus obtain an estimate the number of hard-to-
reach groups of interest (Bernard et al., 2010; Johnsen et al., 1995,
1989). The indirect nature of data collection, the ability of this
method to estimate the size of different subpopulations
concurrently, its low cost and simplicity makes it a feasible
method for size estimation in situations where the usefulness of
other methods such as enumeration, capture-recapture and
multiplier is doubtful due to limited access to reliable data
sources (Guo et al., 2013; Rastegari et al., 2013, 2014; Salganik
et al., 2011a)Due to the signiﬁcance of determining a reliable and updated
estimate of the size of the drug user population by age, gender and
types of substance for policy making, planning and surveillance
purposes, we designed a national survey to estimate the size of
illicit drug use in the entire country using NSU methodology. The
policy makers and other health professionals may beneﬁt from the
results of this study in planning prevention and treatment
interventions as well as in resource allocation and in monitoring
the trend over time. It seems that not only in Iran, but also in the
Eastern Mediterranean Region, this is the ﬁrst time such a study
was implemented on a national scale.
Methods
Sampling and data collection
In this cross-sectional study we recruited 7535 individuals from
all provinces of Iran. Based on a pilot study in Kerman, the lowest
prevalence of a speciﬁc drug use was 1.2%, which corresponded to
injecting drugs (Shokoohi et al., 2012). We set the precision to be
0.2 of prevalence and type one error at 0.05. The sample size
nationally was estimated at 7000. In the end we recruited
7535 participants from 31 provinces. The average sample size in
each province was approximately 400, ranging from 200 to
1000. Because about three-quarters of the Iranian population live
in capital cities, we tried to keep this ratio in our sample. So, 75% of
the sample from each province was recruited from the capital and
the remaining 25% was recruited from one of the large cities of that
province.
Eligible persons were individuals over 18 years of age who had
lived in Iran for at least ﬁve years prior to the survey. We
implemented a self-administered, street-based questionnaire on
passersby from the general public who met the eligibility criteria.
The rational for choosing these respondents was that in a previous
study, we compared the odds of information disclosure in response
to sensitive questions in three interview methods (street-based,
household, and telephone interviews). The results showed that
street-based interviewing provides a higher rate of disclosing
drug-related behaviors and sexual practices than telephone and
household interviewing (Haghdoost et al., 2013). Based on social
and economic classes, each city was stratiﬁed into three zones. In
each stratum, two to four streets were selected randomly. Because
we recruited participants non-randomly, we asked our trained
interviewers to recruit all age, sex and socio-economic groups into
the sample via quota sampling. Quotas were set for gender (50%
male, 50% female), age (50% between 18 and 30, 50% above 30%)
and socio-economic status. Furthermore, we compared the sex-age
distribution of sample with whole country census data, the
difference was not signiﬁcant. To maximize the conﬁdentiality,
we asked the interviewers not to select respondents from ofﬁces,
shops, or similar places. If any invited subject refused to
participate, replacement was done. The questionnaires were ﬁlled
out anonymously. The questionnaire consisted of questions on
demographic information as well as questions to measure the
network size of participants and the number of participants in each
of the seven drug use subgroups (Rastegari et al., 2013).
Applying network scale-up methodology
The NSU method is based on the assumption that by calculating
the proportion of drug users in the social network of a
representative sample of the general population (m/C), the
prevalence of drug use in the whole population can be estimated.
We calculated the average number of drug users in the personal
network of participants (m) by asking them how many people they
knew who belong to each of seven target groups including:
Table 1
Demographic information of participants.
Demographic characteristics Frequency (%)
Gender Male 3584 (48.2)
Female 3853 (51.8)
Age 18–30 3996 (53.03)
>30 3539 (46.9)
Marital status Single 3155 (42.3)
Married 3899 (52.3)
Divorced/widowed 295 (4)
Education High school diploma/under diploma 4237 (56.9)
University/Bachelor 2847 (38.3)
Master and upper 358 (4.8)
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of raw opium and Sookhteh which is opium dross remaining after
the opium is smoked or taken orally).
- Opium sap users (locally named Shire which is a reﬁned product
of opium that is obtained mainly from Sookhteh, with or without
adding opium, boiled in water and ﬁltered several times to
remove the insoluble materials (Khademi et al., 2012).
- New synthetic drug users including: amphetamine and/or
ecstasy and/or LSD (A-E-L) users.
- Crystal methamphetamine users (locally called Shisheh).
- Heroin and/or crack (H-C) users (The components of crack that is
available in Iran are not the same as in crack cocaine. Instead of
cocaine, Iranian crack contains mostly heroin, codeine, morphine
and caffeine with or without other drugs. So because of
similarities between heroin and Iranian crack, we grouped these
two types of drugs together) (Farhoudian et al., 2014; Kazemifar
et al., 2011).
- Hashish and/or cannabis (H-M) users.
- People who inject drugs (PWID).
The deﬁnition of ‘‘know’’ was ‘‘people whom you know and who
know you, in appearance or by name, with whom you can interact,
if needed, and with whom you have contacted over the last two
years personally, or by telephone or e-mail’’ (Midanik & Greenﬁeld,
2003; Rastegari et al., 2013). ‘‘Drug use’’ was deﬁned as at least one
occasion of substance use during the one year preceding the
survey. We estimated the average network size of the Iranian
population at 308 (Rastegari et al., 2013). We asked more than
7000 respondents to describe the frequency of 23 reference groups
with known sizes (for example, the number of men named Hamed
and the number of people who work in an elementary school) in
their network. To estimate the size of substance users based on age
and sex groups, we asked participant to characterize the sex and
age group (<18 years, 18–30 years, >30 years) of nominated
persons. We assumed that the prevalence of the reference groups
in the country is proportional to that of our respondents. To
exclude unreliable reference groups, regression and ratio-based
approaches were followed. To validate the results, data splitting
was applied. We concluded that 308 was a solid ﬁgure to describe
the network size of the Iranian population. The details on
estimating the network size of participants (C) and validation
process are available elsewhere (Rastegari et al., 2013).
Data analysis
Since the NSU method assumes that respondents are aware of
the behavior of other members of their network, and that the
members of the general population have an equal chance of
knowing anyone in the target group (McCormick et al., 2010;
Salganik et al., 2011b; Shelley et al., 2006), we adjusted the
estimates based on two correction factors: transmission and
barrier ratios. As an example, a visibility of 0.50 means that crude
NSU estimates must be divided by 0.5, or doubled. These correction
factors were extracted from previous studies on people who inject
drugs in Iran (Maghsoudi et al., 2014). Accordingly, transmission
ratio and barrier ratio for all types of drug were 0.54 and 0.7,
respectively. The only two exceptions were transmission ratio for
Heroin/Crack (0.65) and barrier ratio for Amphetamine/LSD/
Ecstasy (1). We divided the crude NSU estimate by visibility and
popularity factors to adjust for these two sources of bias. To
provide the uncertainty level for estimates, we applied the Monte
Carlo technique. We used the below equation to estimate the 95%
conﬁdence interval for estimates.
jˆe ¼
P
imijP
ici
t 1
vf
 1
bfIn this equation t (the total number of the general population)
and
P
ici the network size of respondents) are ﬁxed but the other
three components
P
imij (number of people in a particular
subgroup j that the respondent knows), vf (visibility factor) and
bf (barrier factor) are random components. We assumed that
P
imij
(measured as frequency) follow Poisson distribution while vf and
bf (which their values range from 0 to 1) follow uniform
distribution. To provide uncertainty ranges (95% CI) for estimates,
we generated randomly 1000 Poisson distribution with the mean
of
P
imij and allowed vfs vary by 10%. Percentiles of 2.5 and
97.5 were considered as lower and upper bounds of conﬁdence
interval, respectively. All analysis was done using SPSS.20 and
Stata.11 software.
Ethical consideration
The study protocol was approved and reviewed by the research
ethics committees of both Kerman University of Medical sciences
(ethic no: 163/90/KA) and the Iranian Ministry of Health. Before
gathering sufﬁcient data and completing the required question-
naires, an informed consent was obtained from all respondents.
They were assured that all information and discussions would
remain conﬁdential and were informed that their participation
was voluntary. During the interviewing, participants were free to
discontinue the study at any time.
Results
The analysis of data related to 7535 participants from
31 provinces showed that 48.2% of them were men and 51.8%
were women (Table 1). The mean age (standard deviation) of men
and women was 30.79 (11.28) and 30.80 (10.11), respectively. Age
ranged between 18 and 87 years old. Over half of the participants
were married (52.3%) and had a high school diploma/less than high
school diploma level of education (56.9%).
Our results indicate the most common type of illicit drug used
was opium with the prevalence of 1500 per 100,000 persons, that
was followed by shire (660), crystal methamphetamine (590),
hashish (470), heroin/crack (350/100,000), stimulants (metham-
phetamine, LSD and ecstasy) (300/100,000) and injecting drugs
(280/100,000). All types of substance use were at least four times
(for stimulants) more common among men than women (180,000
vs. 44,000, respectively). The largest difference between the two
genders was related to injecting drugs in which the estimated size
for men was more than 12 times higher than in women (193,000
vs. 16,000, respectively). Table 2 shows the estimated size of each
substance use group in the country based on gender and age.
Among three age groups, the lowest estimated size was related to
the population under 18. The number of people who use opium and
shire in the above 30 age group was 784,000 and 352,000,
respectively which is higher than corresponding estimates both in
Table 2
The prevalence and estimated size of various groups of drug users according to gender and age.
Prevalence/
100,000
population
Total estimate
(CI 95%)
Men (CI 95%) Women (CI 95%) Less than 18
(CI 95%)
18-30 (CI 95%) More than 30
(CI 95%)
Opium 1500 1,100,000 1,033,000 79,000 5,400 340,000 784,000
(973,000, 1,273,000) (912,000, 1,186,000) (68,000, 91,000) (4000, 6900) (299,000, 390,000) (693,000, 897,000)
Shire 660 493,000 449,000 45,000 1600 140,000 352,000
(438,000, 566,000) (398,000, 515175,000) (39,000, 53,000) (1000, 2000) (123,000, 160,000) (311,000, 399,000)
Amphetamine/
Ecstasy/LSD
300 224,000 180000 44,000 15,000 167,000 40,000
(206,000, 247,000) (164,000, 200,000) (39,000, 49,000) (13,000, 17,000) (153,000, 185,000) (35,000, 45,000)
Crystal
methamphetamine
590 440,000 394,000 46,000 8000 253,000 176,000
(387,000, 502,000) (349,000, 451,000) (40,000, 54,000) (7000, 10,000) (221,000, 289,000) (156,000, 202,000)
Heroin/crack 350 262,000 241,000 22,000 2900 135,000 124,000
(235,000, 296,000) (214,000, 273,000) (19,000, 25,000) (2000, 3600) (121,000, 154,000) (111,000, 140,000)
Hashish
(cannabi0073)
470 353,000 326,000 28,000 11,000 254,000 87,000
(312,000, 403,000) (286,000, 373,000) (25,000, 33,000) (9000, 13,000) (224,000, 292,000) (76,000, 100,000)
Injecting drugs 280 208,000 193,000 16,000 900 102,000 106,000
(183,000, 238,000) (170,000, 220,000) (13,000, 19,000) (500, 1400) (89,000, 117,000) (92,000, 122,000)
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(340,000 and 140,000). Whereas regarding stimulants and hashish,
the largest size pertained to individuals between 18 and 30
(253,000 for crystal methamphetamine and 254,000 for hashish)
which is comparable to corresponding estimates in under 18
(15,000 and 900, respectively) and above 30 (176,000 and 106,000
in that order) groups. The lowest estimates for heroin/crack and
injecting drugs was related to population under 18 (2900 for
heroin/crack and 900 for injecting drugs) but there were no
substantial differences between age groups above 30 and 18–30
concerning heroin/crack (124,000 vs. 135,000) and injecting drugs
(106,000 vs. 102,000). Table 2 shows the total estimated size and
prevalence of each type of drug use per 100,000 persons.
Discussion
This study revealed that opium, shire and crystal methamphet-
amine are the most common types of drugs used in Iran, but the
pattern varies somewhat based on age and sex. In both genders,
opium, shire and crystal methamphetamine are the three most
common types of drugs used. The only difference between the two
genders is that after opium, crystal methamphetamine is the
second most common substance for women but the third for men.
Generally, women are less affected by drugs. The estimated
number of men was between four times (for amphetamine, ecstasy
and LSD) and 12 times (for injecting drugs) higher than women.
While older individuals tend to use traditional types of drugs,
younger people are more likely to use new synthetic ones.
Although we do not have any updated ofﬁcial estimation with
which to compare the results and cross-validate the ﬁndings, the
latest rapid situation assessment of drug use and dependency in
Iran (RSA), conducted in 2007, estimated the prevalence of drug
use to be 2.4%. They also reported the total number of drug users to
be 1.2 million, of which 200,000 of them are PWID (Narenjiha et al.,
2007). Analogous to our results, the most common drugs in that
study were opium, crack and heroin, in that order. Additionally, the
results of a national household survey in 2011 indicated that nearly
3% of the Iranian population uses some type of drug. Based on their
reports, opium, followed by crystal methamphetamine, then crack
and heroin were the most prevalent types of drugs used (Sarrami
et al., 2013).
Analyzing the evidence, it seems that the use of new, synthetic
drugs, especially crystal methamphetamine, has become a health
concern in recent years (Alam-mehrjerdi et al., 2015; Noori, 2011).
The results of the RSA in 2007 indicated that 6.3% of substance
users used methamphetamine. Although there are nearly 6000 cen-
ters supervised by medical sciences universities, state welfareorganizations and prison organizations which provide methadone
maintenance therapy (MMT) and buprenorphine maintenance
therapy (BMT) for the approximately half million people who use
opiates (including opium, crack/heroin and shire users), there is
only a limited number of treatment clinics for other types of
substances (Alam-mehrjerdi et al., 2014; Iranian Ministry of Health
and Medical Education, 2015). Moreover, many individuals who
undergo opiate maintenance treatment concurrently use stimu-
lants for many reasons (e.g. feeling good and getting high in the
absence of the drug) (Shariatirad et al., 2013). This situation
potentially reduces the effectiveness of MMT or BMT (Shariatirad
et al., 2013). Inexperience of clinicians and psychologists who are
involved in MMT/BMT regarding the treatment of stimulants
makes the treatment of the affected population more complicated.
This results in most synthetic drug users having no access to
appropriate treatment services. Therefore the extension of such
treatments nationwide and revising the available treatment
protocols into comprehensive guidelines which also cover
modalities for parallel drug use are needed.
We have learned that the pattern of drug use varies by the age of
the individual. Opium, amphetamine/ecstasy/LSD and shire are the
most common types of drugs among the population over 30. In the
groups 18–30 and under 18, the most common type of drug is
opium then amphetamine/ecstasy/LSD. In both of these age
groups, hashish and crystal methamphetamine are the second
and third most common drug used. It seems that younger people
tend to use new, synthetic drugs more than traditional substances
while individuals in older age groups are more likely to use
traditional substances such as opium and shire. Considering the
psycho-social and physical complications and complexities of
treatment, use of synthetic drugs has turned into one of the main
challenges in relationship to substance use among youth and their
families (Russell et al., 2008). Lack of appropriate knowledge, the
reasonable price, ease of use and the positive attitude toward these
drugs are potential explanations for the elevated tendency of youth
toward new synthetic drugs. Most of substance use prevention
programs among youth in Iran are implemented through the
media. Education in school only covers about 8% of schools (Islamic
Republic News Agency, 2015).
Gender is another challenge in control of drug use in Iran. As the
results show, in both genders, opium, shire and crystal metham-
phetamine are the most common types of drugs used.
It is reported that between 6% and 10% of substance users in Iran
are female (Noori, 2011; Khajedaluee & Moghadam, 2013; Sarrami
et al., 2013; Tavakoli et al., 2014). Our estimates show that the
difference between males and females may vary based on types of
drugs. Although generally women are less affected by drugs than
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of substance use in both genders, the rise is more accelerated in
women, especially regarding stimulants (Noori, 2011). Women
constitute only 2–6% of the population who seek treatment in drug
treatment clinics in Iran (Tavakoli et al., 2014), which corresponds
to 9600–28,800 individuals out of all 4800 treatment seekers. If
we only consider the number of women who use opium (78,800)
the poor availability of treatment services for women would be
evident. Indeed, Iranian women experience more stigma being
drug users and consequently are more reluctant to seek treatment
(Dolan et al., 2011).
Regarding the registered cases of opiate users in drug treatment
clinics (0.5 million) (Iranian Ministry of Health and Medical
Education, 2015) our estimates indicate that less than half of opiate
users are under the coverage of drug treatment centers.
Additionally based on a MOH report of the half million people
who received drug maintenance treatment, only 26,000 were
PWID (Iranian Ministry of Health and Medical Education, 2015).
Considering the estimated size of PWID in our study (208,000), this
corresponds to 12.5% of all PWID. A cross-sectional study on
572 PWID in Tehran also revealed that only a small portion of PWID
(9%) used drug treatment services, while majority of them (55%)
had access to needle exchange programs (NEP) (Rahnama et al.,
2014). It is estimated that 13.5% of PWID in Iran are HIV positive.
Because this estimate has been extracted from national bio-
behavioral surveillance among PWID who are referred to facilities,
it cannot reﬂect the HIV prevalence of all PWID in the community.
We therefore cannot estimate the number of HIV-positive cases
based on the estimated number of this subgroup. Nevertheless,
increasing harm reduction services could have substantial effect
on reducing HIV incidence and transmission in this key group
(Nasirian et al., 2012).
Estimations based on NSU, in comparison to both direct
interview and using secondary data sources, may provide higher
numbers of prevalence of drug use (Salganik et al., 2011a). This is
because in direct interview, respondents usually tend to underre-
port their stigmatized behaviour. The main limitation of some
secondary data sources, such as mandatory drug screening that are
implemented before marriage, getting governmental jobs or
obtaining licences, is the foreknowledge of individuals about
screenings. In other sources of data, such as prison inmates and
police arrestees, gender imbalance may limit the generalizability
of the results (Razzaghi et al., 1999).
We acknowledge the limitations of this study. As stated later,
the prevalence of all types of drug use was very low in age groups
under 18. Some amounts of underestimation are possible in this
age group. On the other hand about 42.5% of our sample had
university degree which differs with corresponding number of 18%
based on latest census in Iran. These may be because in each
province, we recruited respondents from the capital city and also
one of the large cities of that province. Thus because of selection
bias the results could not be generalizable to rural populations.
Lastly, despite the usefulness of NSU in high stigmatized setting,
there is still some source of biases. Because of some practical
constrains, we could not conduct separate studies among different
drug user groups in each province to estimate the transmission and
barrier ratio used to adjust the results. It is possible that cultural
contexts affect the social transparency of drug use behavior. This
effect can differ slightly in various areas of the country. Selection
bias and social desirability bias could not be ruled out due to non-
random sampling and interview-based nature of data collection
respectively. Recall bias is another threat of validity in NSU.
Salganik et al. (2011a) showed that Individuals may have tendency
to overestimate the sizes of smaller populations and underesti-
mate the sizes of larger populations. Our goal for future studies is
to reduce these circumscriptions as much as possible. Nonetheless,the indirect nature of data gathering, low cost and possibility of
concurrent size estimation of various groups are the main
strengths of NSU for size estimation of hidden populations. The
nationwide essence of study and consequently large sample size is
another advantage of our study. Overall, we believe, given the
scope of the study, our ﬁndings have important implications for
both research and policy. To monitor the trend and evaluation of
programs, we highly recommend this survey to be conducted
repeatedly.
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